Citadel Advisors’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Buy
20,005
+295
+1% +$11.4K ﹤0.01% 8781
2026
Q1
$706K Sell
19,710
-1,605
-8% -$59.1K ﹤0.01% 8476
2025
Q4
$785K Buy
+21,315
New +$777K ﹤0.01% 7957
2025
Q3
– Sell
-8,014
Closed -$275K – 13689
2025
Q2
$275K Buy
8,014
+616
+8% +$20K ﹤0.01% 9993
2025
Q1
$236K Buy
+7,398
New +$243K ﹤0.01% 10120
2023
Q4
– Sell
-14,335
Closed -$394K – 14931
2023
Q3
$394K Sell
14,335
-8,664
-38% -$247K ﹤0.01% 8590
2023
Q2
$657K Buy
+22,999
New +$624K ﹤0.01% 7338

Other funds holding NVBT

Citadel Advisors's NVBT Position: Q2 2026 in Review

Citadel Advisors increased its AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) stake by 1.5% in Q2 2026, buying an estimated $11.4K and bringing the position to 20,005 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #8781.

Citadel Advisors first reported a position in NVBT in Q2 2023 and has held it in 7 quarters since. 26 funds tracked by Wall St. Rank hold NVBT as of Q2 2026.

  • Citadel Advisors held 20,005 shares of AllianzIM U.S. Equity Buffer10 Nov ETF worth $792K as of Q2 2026.
  • Citadel Advisors bought 295 AllianzIM U.S. Equity Buffer10 Nov ETF shares in Q2 2026, an estimated $11.4K.
  • AllianzIM U.S. Equity Buffer10 Nov ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8781 holding.
  • Citadel Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q2 2023 and has held it in 7 quarters since.
  • 26 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.